• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    6/7/24 6:09:00 PM ET
    $ADTN
    $ALTR
    $ATNI
    $BMRN
    Telecommunications Equipment
    Utilities
    Computer Software: Prepackaged Software
    Technology
    Get the next $ADTN alert in real time by email

    NEW YORK, June 7, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, June 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space. 

    • KKR & Co Inc. (NYSE:KKR), CrowdStrike Holdings Inc. (NASD: CRWD), and S&P MidCap 400 constituent GoDaddy Inc. (NYSE:GDDY) will replace Robert Half Inc. (NYSE:RHI), Comerica Inc. (NYSE:CMA) and Illumina Inc. (NASD:ILMN) in the S&P 500 respectively, and Illumina will replace GoDaddy in the S&P MidCap 400. Robert Half and Comerica will replace Anywhere Real Estate Inc. (NYSE:HOUS) and ADTRAN Holdings Inc. (NASD:ADTN) in the S&P SmallCap 600. Illumina announced its intention to spin-off a company later this month.



    • Texas Pacific Land Corp.(NYSE:TPL), BioMarin Pharmaceutical Inc.(NASD:BMRN), Warner Music Group Corp. (NASD:WMG), Nextracker Inc. (NASD:NXT), Altair Engineering Inc. (NASD:ALTR), and RB Global Inc. (NYSE:RBA) will replace Werner Enterprises Inc. (NASD:WERN), Integra Lifesciences Holdings Corp. (NASD:IART), PENN Entertainment Inc. (NASD:PENN), Grocery Outlet Holding Corp. (NASD:GO), Leggett & Platt Inc. (NYSE:LEG) and Hertz Global Holdings Inc. (NASD:HTZ) in the S&P MidCap 400 respectively. Leggett & Platt, Hertz Global Holdings, Grocery Outlet Holding, PENN Entertainment, Integra Lifesciences and Werner Enterprises will replace Methode Electronics Inc. (NYSE:MEI), Chatham Lodging Trust (NYSE:CLDT), Northfield Bancorp Inc. (NASD: NFBK), Xperi Inc. (NYSE:XPER), Resources Connection Inc. (NASD:RGP) and ATN International Inc. (NASD:ATNI) in the S&P SmallCap 600 respectively.



    • Krystal Biotech Inc. (NASD:KRYS), Virtu Financial Inc. (NASD:VIRT), StepStone Group Inc. (NASD:STEP), Cactus Inc. (NYSE:WHD), and Tidewater Inc. (NYSE:TDW) will replace OraSure Technologies Inc. (NASD:OSUR), The Marcus Corp. (NYSE:MCS),TTEC Holdings Inc. (NASD:TTEC), Medifast Inc. (NYSE:MED), and Cerence Inc. (NASD:CRNC) in the S&P SmallCap 600 respectively.

    Following is a summary of the changes that will take place prior to the open of trading on the effective date:

    Effective Date

    Index Name      

    Action

    Company Name

    Ticker

    GICS Sector

    June 24, 2024

    S&P 500

    Addition

    KKR & Co

    KKR

    Financials

    June 24, 2024

    S&P 500

    Addition

    CrowdStrike Holdings

    CRWD

    Information Technology

    June 24, 2024

    S&P 500

    Addition

    GoDaddy

    GDDY

    Information Technology

    June 24, 2024

    S&P 500

    Deletion

    Robert Half

    RHI

    Industrials

    June 24, 2024

    S&P 500

    Deletion

    Comerica

    CMA

    Financials

    June 24, 2024

    S&P 500

    Deletion

    Illumina

    ILMN

    Health Care

    June 24, 2024

    S&P MidCap 400

    Addition

    Texas Pacific Land

    TPL

    Energy

    June 24, 2024

    S&P MidCap 400

    Addition

    BioMarin Pharmaceutical

    BMRN

    Health Care

    June 24, 2024

    S&P MidCap 400

    Addition

    Warner Music Group

    WMG

    Communication Services

    June 24, 2024

    S&P MidCap 400

    Addition

    Nextracker

    NXT

    Industrials

    June 24, 2024

    S&P MidCap 400

    Addition

    Altair Engineering

    ALTR

    Information Technology

    June 24, 2024

    S&P MidCap 400

    Addition

    RB Global

    RBA

    Industrials

    June 24, 2024

    S&P MidCap 400

    Addition

    Illumina

    ILMN

    Health Care

    June 24, 2024

    S&P MidCap 400

    Deletion

    Werner Enterprises

    WERN

    Industrials

    June 24, 2024

    S&P MidCap 400

    Deletion

    Integra Lifesciences

    IART

    Health Care

    June 24, 2024

    S&P MidCap 400

    Deletion

    PENN Entertainment

    PENN

    Consumer Discretionary

    June 24, 2024

    S&P MidCap 400

    Deletion

    Grocery Outlet Holding

    GO

    Consumer Staples

    June 24, 2024

    S&P MidCap 400

    Deletion

    Leggett & Platt

    LEG

    Consumer Discretionary

    June 24, 2024

    S&P MidCap 400

    Deletion

    Hertz Global Holdings

    HTZ

    Industrials

    June 24, 2024

    S&P MidCap 400

    Deletion

    GoDaddy

    GDDY

    Information Technology

    June 24, 2024

    S&P SmallCap 600

    Addition

    Comerica

    CMA

    Financials

    June 24, 2024

    S&P SmallCap 600

    Addition

    Leggett & Platt

    LEG

    Consumer Discretionary

    June 24, 2024

    S&P SmallCap 600

    Addition

    Hertz Global Holdings

    HTZ

    Industrials

    June 24, 2024

    S&P SmallCap 600

    Addition

    Grocery Outlet Holding

    GO

    Consumer Staples

    June 24, 2024

    S&P SmallCap 600

    Addition

    PENN Entertainment

    PENN

    Consumer Discretionary

    June 24, 2024

    S&P SmallCap 600

    Addition

    Integra Lifesciences

    IART

    Health Care

    June 24, 2024

    S&P SmallCap 600

    Addition

    Werner Enterprises

    WERN

    Industrials

    June 24, 2024

    S&P SmallCap 600

    Addition

    Krystal Biotech

    KRYS

    Health Care

    June 24, 2024

    S&P SmallCap 600

    Addition

    Virtu Financial

    VIRT

    Financials

    June 24, 2024

    S&P SmallCap 600

    Addition

    StepStone Group

    STEP

    Financials

    June 24, 2024

    S&P SmallCap 600

    Addition

    Cactus

    WHD

    Energy

    June 24, 2024

    S&P SmallCap 600

    Addition

    Tidewater

    TDW

    Energy

    June 24, 2024

    S&P SmallCap 600

    Addition

    Robert Half

    RHI

    Industrials

    June 24, 2024

    S&P SmallCap 600

    Deletion

    ADTRAN Holdings

    ADTN

    Information Technology

    June 24, 2024

    S&P SmallCap 600

    Deletion

    Methode Electronics

    MEI

    Information Technology

    June 24, 2024

    S&P SmallCap 600

    Deletion

    Chatham Lodging Trust

    CLDT

    Real Estate

    June 24, 2024

    S&P SmallCap 600

    Deletion

    Northfield Bancorp

    NFBK

    Financials

    June 24, 2024

    S&P SmallCap 600

    Deletion

    Xperi

    XPER

    Information Technology

    June 24, 2024

    S&P SmallCap 600

    Deletion

    Resources Connection

    RGP

    Industrials

    June 24, 2024

    S&P SmallCap 600

    Deletion

    ATN International

    ATNI

    Communication Services

    June 24, 2024

    S&P SmallCap 600

    Deletion

    OraSure Technologies

    OSUR

    Health Care

    June 24, 2024

    S&P SmallCap 600

    Deletion

    Marcus

    MCS

    Communication Services

    June 24, 2024

    S&P SmallCap 600

    Deletion

    TTEC Holdings

    TTEC

    Industrials

    June 24, 2024

    S&P SmallCap 600

    Deletion

    Medifast

    MED

    Consumer Staples

    June 24, 2024

    S&P SmallCap 600

    Deletion

    Cerence

    CRNC

    Information Technology

    June 24, 2024

    S&P SmallCap 600

    Deletion

    Anywhere Real Estate

    HOUS

    Real Estate

    For more information about S&P Dow Jones Indices, please visit www.spdji.com

    ABOUT S&P DOW JONES INDICES

    S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

    S&P Dow Jones Indices is a division of S&P Global (NYSE:SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.

    FOR MORE INFORMATION:

    S&P Dow Jones Indices

    [email protected]

    Media Inquiries

    [email protected]

    Cision View original content:https://www.prnewswire.com/news-releases/kkr-crowdstrike-holdings-and-godaddy-set-to-join-sp-500-others-to-join-sp-midcap-400-and-sp-smallcap-600-302167485.html

    SOURCE S&P Dow Jones Indices

    Get the next $ADTN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADTN
    $ALTR
    $ATNI
    $BMRN

    CompanyDatePrice TargetRatingAnalyst
    CrowdStrike Holdings Inc.
    $CRWD
    1/9/2026$600.00Hold → Buy
    Berenberg
    Grocery Outlet Holding Corp.
    $GO
    1/8/2026Hold
    Deutsche Bank
    Werner Enterprises Inc.
    $WERN
    1/6/2026$34.00Underweight → Equal Weight
    Wells Fargo
    Krystal Biotech Inc.
    $KRYS
    1/6/2026$309.00Neutral → Buy
    Citigroup
    Warner Music Group Corp.
    $WMG
    12/18/2025$37.00Equal-Weight → Overweight
    Morgan Stanley
    KKR & Co. Inc.
    $KKR
    12/11/2025$176.00Buy
    UBS
    Cactus Inc.
    $WHD
    12/11/2025$55.00Neutral → Buy
    Citigroup
    Robert Half Inc.
    $RHI
    12/5/2025$22.00Neutral → Underperform
    BNP Paribas Exane
    More analyst ratings

    $ADTN
    $ALTR
    $ATNI
    $BMRN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CrowdStrike upgraded by Berenberg with a new price target

    Berenberg upgraded CrowdStrike from Hold to Buy and set a new price target of $600.00

    1/9/26 8:27:17 AM ET
    $CRWD
    Computer Software: Prepackaged Software
    Technology

    Deutsche Bank initiated coverage on Grocery Outlet

    Deutsche Bank initiated coverage of Grocery Outlet with a rating of Hold

    1/8/26 10:59:22 AM ET
    $GO
    Food Chains
    Consumer Staples

    Werner Enterprises upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Werner Enterprises from Underweight to Equal Weight and set a new price target of $34.00

    1/6/26 8:28:47 AM ET
    $WERN
    Trucking Freight/Courier Services
    Industrials

    $ADTN
    $ALTR
    $ATNI
    $BMRN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Horizon Kinetics Asset Management Llc bought $292 worth of shares (1 units at $291.90), increasing direct ownership by 0.00% to 3,488,094 units (SEC Form 4)

    4 - Texas Pacific Land Corp (0001811074) (Issuer)

    1/9/26 11:13:52 AM ET
    $TPL
    Oil & Gas Production
    Energy

    Large owner Horizon Kinetics Asset Management Llc bought $286 worth of shares (1 units at $286.30), increasing direct ownership by 0.00% to 3,488,093 units (SEC Form 4)

    4 - Texas Pacific Land Corp (0001811074) (Issuer)

    1/8/26 4:59:20 PM ET
    $TPL
    Oil & Gas Production
    Energy

    Amendment: Large owner Horizon Kinetics Asset Management Llc bought $297 worth of shares (1 units at $296.79) and was granted 554 shares, decreasing direct ownership by 99% to 25,268 units (SEC Form 4)

    4/A - Texas Pacific Land Corp (0001811074) (Issuer)

    1/8/26 4:27:14 PM ET
    $TPL
    Oil & Gas Production
    Energy

    $ADTN
    $ALTR
    $ATNI
    $BMRN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 29, 2023 - FDA Approves First Gene Therapy for Adults with Severe Hemophilia A

    For Immediate Release: June 29, 2023 Today, the U.S. Food and Drug Administration approved Roctavian, an adeno-associated virus vector-based gene therapy for the treatment of adults with severe hemophilia A without pre-existing antibodies to adeno-associated virus serotype 5 detected by an FDA-approved test. “Hereditary hemophilia A is a potentially serious bleeding disorder. Severe cases of hemophilia A can ca

    6/29/23 6:02:12 PM ET
    $BMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    May 19, 2023 - FDA Approves First Topical Gene Therapy for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa

    For Immediate Release: May 19, 2023 Today, the U.S. Food and Drug Administration approved Vyjuvek, a herpes-simplex virus type 1 (HSV-1) vector-based gene therapy, for the treatment of wounds in patients 6 months of age and older with dystrophic epidermolysis bullosa (DEB) with mutation(s) in the collagen type VII alpha 1 chain (COL7A1) gene.  “Vyjuvek is the first FDA-approved gene therapy treatment for DEB, a

    5/19/23 1:48:20 PM ET
    $KRYS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADTN
    $ALTR
    $ATNI
    $BMRN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    S&P Global Schedules Fourth Quarter and Full-Year 2025 Earnings Announcement and Conference Call for Tuesday, February 10, 2026

    NEW YORK, Jan. 9, 2026 /PRNewswire/ -- S&P Global's (NYSE: SPGI) fourth quarter and full-year 2025 results will be issued on Tuesday, February 10, 2026 via news release at approximately 7:15 a.m. Eastern Time. The news release will be available at www.spglobal.com. Martina Cheung, President and CEO; Eric Aboaf, Chief Financial Officer; and Mark Grant, Senior Vice President, Investor Relations and Treasurer, will host a conference call and webcast at 8:30 a.m. Eastern Time on February 10, 2026 to discuss the Company's fourth quarter and full-year 2025 financial results. The presentation is open to all interested parties and may include forward-looking information. The presenters' slides, sup

    1/9/26 2:42:00 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    Illumina Appoints Dr. Eric Green as Chief Medical Officer

    Veteran genomics leader joins Illumina to advance global medical strategyIllumina chief commercial officer to depart for role as a life science tools company CEO  SAN DIEGO, Jan. 8, 2026 /PRNewswire/ -- Today, Illumina, Inc. (NASDAQ:ILMN) announced the appointment of Eric D. Green, M.D., Ph.D., as Chief Medical Officer (CMO), effective February 2. In this role reporting to the CEO, Dr. Green will accelerate the company's mission to drive a revolution in medicine by unlocking the power of the genome. Dr. Green will serve as a key scientific and medical leader representing Illumina, helping advance the clinical use of genomics, expand access to precision medicine solutions, and increase the di

    1/8/26 4:30:00 PM ET
    $ILMN
    Medical Specialities
    Health Care

    Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026

    Planned Leadership Transition Positions Company for Growth Company Expects to Exceed Revenue and Cash Guidance for the Full Year 2025 Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that its Board of Directors (the "Board") has appointed Everett Cunningham as the Company's next President and Chief Executive Officer and a member of the Board, effective January 19, 2026. Mr. Cunningham will succeed Masoud Toloue, who will continue to serve as Chief Executive Officer until Mr. Cunningham assumes the role on January 19, 2026. Following Mr. Cunningham

    1/8/26 4:30:00 PM ET
    $ARVN
    $DGX
    $EXAS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical Specialities
    Biotechnology: Laboratory Analytical Instruments

    $ADTN
    $ALTR
    $ATNI
    $BMRN
    SEC Filings

    View All

    KKR & Co. Inc. filed SEC Form 8-K: Leadership Update

    8-K - KKR & Co. Inc. (0001404912) (Filer)

    1/9/26 4:30:43 PM ET
    $KKR
    Investment Managers
    Finance

    SEC Form S-8 POS filed by Anywhere Real Estate Inc.

    S-8 POS - Anywhere Real Estate Inc. (0001398987) (Filer)

    1/9/26 4:08:31 PM ET
    $HOUS
    Real Estate
    Finance

    SEC Form S-8 POS filed by Anywhere Real Estate Inc.

    S-8 POS - Anywhere Real Estate Inc. (0001398987) (Filer)

    1/9/26 4:08:02 PM ET
    $HOUS
    Real Estate
    Finance

    $ADTN
    $ALTR
    $ATNI
    $BMRN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: New insider Moore Michael S. claimed ownership of 850,453 shares (SEC Form 3)

    3/A - HERTZ GLOBAL HOLDINGS, INC (0001657853) (Issuer)

    1/9/26 5:07:12 PM ET
    $HTZ
    Rental/Leasing Companies
    Consumer Discretionary

    EVP, Chief Strategy Officer Chesin Eric M. was granted 84,936 units of Common Stock and returned 187,872 units of Common Stock to the company, closing all direct ownership in the company (SEC Form 4)

    4 - Anywhere Real Estate Inc. (0001398987) (Issuer)

    1/9/26 4:10:37 PM ET
    $HOUS
    Real Estate
    Finance

    SVP, Chief Accounting Officer Gustavson Timothy B. returned 19,028 shares to the company, closing all direct ownership in the company (SEC Form 4)

    4 - Anywhere Real Estate Inc. (0001398987) (Issuer)

    1/9/26 4:10:42 PM ET
    $HOUS
    Real Estate
    Finance

    $ADTN
    $ALTR
    $ATNI
    $BMRN
    Leadership Updates

    Live Leadership Updates

    View All

    Illumina Appoints Dr. Eric Green as Chief Medical Officer

    Veteran genomics leader joins Illumina to advance global medical strategyIllumina chief commercial officer to depart for role as a life science tools company CEO  SAN DIEGO, Jan. 8, 2026 /PRNewswire/ -- Today, Illumina, Inc. (NASDAQ:ILMN) announced the appointment of Eric D. Green, M.D., Ph.D., as Chief Medical Officer (CMO), effective February 2. In this role reporting to the CEO, Dr. Green will accelerate the company's mission to drive a revolution in medicine by unlocking the power of the genome. Dr. Green will serve as a key scientific and medical leader representing Illumina, helping advance the clinical use of genomics, expand access to precision medicine solutions, and increase the di

    1/8/26 4:30:00 PM ET
    $ILMN
    Medical Specialities
    Health Care

    Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026

    Planned Leadership Transition Positions Company for Growth Company Expects to Exceed Revenue and Cash Guidance for the Full Year 2025 Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that its Board of Directors (the "Board") has appointed Everett Cunningham as the Company's next President and Chief Executive Officer and a member of the Board, effective January 19, 2026. Mr. Cunningham will succeed Masoud Toloue, who will continue to serve as Chief Executive Officer until Mr. Cunningham assumes the role on January 19, 2026. Following Mr. Cunningham

    1/8/26 4:30:00 PM ET
    $ARVN
    $DGX
    $EXAS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical Specialities
    Biotechnology: Laboratory Analytical Instruments

    Medifast Announces Planned Leadership Transition

     Nicholas Johnson Appointed President, and Expected to Succeed Dan Chard as CEO in June 2026; Chard to Remain Chairman Medifast, Inc. (NYSE:MED) today announced a planned leadership transition designed to provide continuity and stability as the company continues its evolution toward metabolic health. Medifast Chairman & Chief Executive Officer Dan Chard has informed the Board of Directors that he plans to step down as Chief Executive Officer in June 2026. Chard will continue to serve as Chairman of the Board following the transition. The Board has appointed Medifast's Chief Field Operations Officer Nicholas Johnson as President of Medifast, effective immediately. Johnson will work clo

    1/5/26 9:00:00 AM ET
    $MED
    Packaged Foods
    Consumer Staples

    $ADTN
    $ALTR
    $ATNI
    $BMRN
    Financials

    Live finance-specific insights

    View All

    S&P Global Schedules Fourth Quarter and Full-Year 2025 Earnings Announcement and Conference Call for Tuesday, February 10, 2026

    NEW YORK, Jan. 9, 2026 /PRNewswire/ -- S&P Global's (NYSE: SPGI) fourth quarter and full-year 2025 results will be issued on Tuesday, February 10, 2026 via news release at approximately 7:15 a.m. Eastern Time. The news release will be available at www.spglobal.com. Martina Cheung, President and CEO; Eric Aboaf, Chief Financial Officer; and Mark Grant, Senior Vice President, Investor Relations and Treasurer, will host a conference call and webcast at 8:30 a.m. Eastern Time on February 10, 2026 to discuss the Company's fourth quarter and full-year 2025 financial results. The presentation is open to all interested parties and may include forward-looking information. The presenters' slides, sup

    1/9/26 2:42:00 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    Krystal Biotech Announces Positive Interim Clinical Update from KB407 Phase 1 CORAL-1 Study with Confirmation of Wild-Type CFTR Delivery to the Lungs of Patients with Cystic Fibrosis

    Confirmed wild-type CFTR delivery and expression in conducting airway cells of patients with class I mutations KB407 transduction confirmed in all six patients with successful bronchoscopies irrespective of modulator-status; percentage of conducting airway cells transduced in each patient ranged from 29.4% to 42.1% Registrational repeat dosing CORAL-3 study design submitted to FDA in late December; anticipating enrollment in study to start in 1H 2026 following alignment with the FDA Investor call to be held January 8 at 4:30 pm ET to discuss data update and timelines for KB407 repeat dosing study start PITTSBURGH, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company"

    1/8/26 4:01:00 PM ET
    $KRYS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Resources Connection Reports Financial Results for Second Quarter Fiscal 2026

    Resources Connection, Inc. (NASDAQ:RGP) (the "Company"), a professional services firm, today announced its financial results for its second quarter of fiscal 2026 ended November 29, 2025. Second Quarter Fiscal 2026 Highlights Compared to Prior Year Quarter: Revenue of $117.7 million compared to $145.6 million Same-day constant currency revenue, a non-GAAP measure, declined by 18.4% Gross margin of 37.1% compared to 38.5% Selling, general and administrative expenses ("SG&A") of $54.4 million compared to $51.3 million Adjusted SG&A, a non-GAAP measure, of $39.7 million compared to $46.5 million, an improvement of 15%. Net loss of $12.7 million (net loss margin of 10.8%) co

    1/7/26 4:05:00 PM ET
    $RGP
    Real Estate

    $ADTN
    $ALTR
    $ATNI
    $BMRN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Texas Pacific Land Corporation

    SC 13G/A - Texas Pacific Land Corp (0001811074) (Subject)

    12/6/24 10:11:20 AM ET
    $TPL
    Oil & Gas Production
    Energy

    Amendment: SEC Form SC 13G/A filed by Illumina Inc.

    SC 13G/A - ILLUMINA, INC. (0001110803) (Subject)

    12/6/24 10:11:24 AM ET
    $ILMN
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Illumina Inc.

    SC 13G - ILLUMINA, INC. (0001110803) (Subject)

    12/5/24 7:27:01 PM ET
    $ILMN
    Medical Specialities
    Health Care